{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T07:49:11Z","timestamp":1790668151858,"version":"4.1.0"},"reference-count":65,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1097\/aco.0000000000000735","type":"journal-article","created":{"date-parts":[[2019,4,6]],"date-time":"2019-04-06T09:25:08Z","timestamp":1554542708000},"page":"398-404","source":"Crossref","is-referenced-by-count":42,"title":["Recent advances in diabetes treatments and their perioperative implications"],"prefix":"10.1097","volume":"32","author":[{"given":"Deniz","family":"Kuzulugil","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabrielle","family":"Papeix","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judy","family":"Luu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ross K.","family":"Kerridge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R3-22-20210129","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1111\/j.1464-5491.2012.03582.x","article-title":"Diabetes UK position statements and care recommendations: NHS diabetes guideline for the perioperative management of the adult patient with diabetes","volume":"29","author":"Dhatariya","year":"2012","journal-title":"Diabet Med"},{"key":"R4-22-20210129","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1097\/SLA.0000000000000688","article-title":"Perioperative hyperglycemia and risk of adverse events among patients with and without diabetes","volume":"261","author":"Kotagal","year":"2015","journal-title":"Ann Surg"},{"key":"R5-22-20210129","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1097\/SLA.0b013e31827b6bbc","article-title":"Importance of perioperative glycemic control in general surgery: a report from the Surgical Care and Outcomes Assessment Program","volume":"257","author":"Kwon","year":"2013","journal-title":"Ann Surg"},{"key":"R7-22-20210129","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1097\/CCM.0000000000002255","article-title":"Surviving sepsis campaign: international guidelines for management of sepsis and septic shock: 2016","volume":"45","author":"Rhodes","year":"2017","journal-title":"Crit Care Med"},{"key":"R8-22-20210129","first-page":"451","article-title":"Glycemic control reduces infections in postliver transplant patients: results of a prospective, randomized study","volume":"102","author":"Wallia","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"key":"R9-22-20210129","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1097\/SLA.0000000000002323","article-title":"Effect of preoperative diabetes management on glycemic control and clinical outcomes after elective surgery","volume":"267","author":"Garg","year":"2018","journal-title":"Ann Surg"},{"key":"R10-22-20210129","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.diabres.2013.05.003","article-title":"Intensity of peri-operative glycemic control and postoperative outcomes in patients with diabetes: a meta-analysis","volume":"102","author":"Sathya","year":"2013","journal-title":"Diabetes Res Clin Pract"},{"key":"R13-22-20210129","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.diabet.2018.01.014","article-title":"Practical management of diabetes patients before, during and after surgery: a joint French diabetology and anaesthesiology position statement","volume":"44","author":"Cosson","year":"2018","journal-title":"Diabetes Metab"},{"key":"R16-22-20210129","first-page":"1427","article-title":"Peri-operative management of the surgical patient with diabetes.","volume":"70","year":"2015","journal-title":"Anaesthesia"},{"key":"R17-22-20210129","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1001\/jamasurg.2016.4952","article-title":"Enhanced recovery after surgery","volume":"152","author":"Ljungqvist","year":"2017","journal-title":"JAMA Surg"},{"key":"R18-22-20210129","doi-asserted-by":"crossref","first-page":"e54","DOI":"10.1213\/ANE.0000000000003675","article-title":"Preoperative continuation versus interruption of oral hypoglycemics in type 2 diabetic patients undergoing ambulatory surgery: a randomized controlled trial","volume":"127","author":"Gasanova","year":"2018","journal-title":"Anesth Analg"},{"key":"R20-22-20210129","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1001\/jamainternmed.2018.0292","article-title":"Association of metformin use with risk of lactic acidosis across the range of kidney function","volume":"178","author":"Lazarus","year":"2018","journal-title":"JAMA Intern Med"},{"key":"R21-22-20210129","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/s40360-017-0145-6","article-title":"Metformin is not associated with lactic acidosis in patients with diabetes undergoing coronary artery bypass graft surgery: a case control study","volume":"18","author":"Nazer","year":"2017","journal-title":"BMC Pharmacol Toxicol"},{"key":"R22-22-20210129","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1111\/dom.13118","article-title":"Peri-operative continuation of metformin does not improve glycaemic control in patients with type 2 diabetes: a randomized controlled trial","volume":"20","author":"Hulst","year":"2018","journal-title":"Diabetes Obes Metab"},{"key":"R23-22-20210129","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/jdi.12676","article-title":"Continuous glucose monitoring reveals hypoglycaemia risk in elderly patients with type 2 diabetes mellitus","volume":"9","author":"Ishikawa","year":"2018","journal-title":"J Diabetes Investig"},{"key":"R24-22-20210129","doi-asserted-by":"crossref","first-page":"706","DOI":"10.2337\/dc16-1943","article-title":"Sulfonylureas and the risk of cardiovascular events and death: a methodological meta-regression analysis of the observational studies","volume":"40","author":"Azoulay","year":"2017","journal-title":"Diabetes Care"},{"key":"R25-22-20210129","doi-asserted-by":"crossref","first-page":"S146","DOI":"10.2337\/dcS15-3003","article-title":"Treatment of type 2 diabetes: from \u2018Guidelines\u2019 to \u2018Position Statements\u2019 and back: recommendations of the Israel National Diabetes Council","volume":"39","author":"Mosenzon","year":"2016","journal-title":"Diabetes Care"},{"key":"R26-22-20210129","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1210\/er.2010-0029","article-title":"Role of sodium-glucose contrasporter 2 (SGLT2) inhibitors in the treatment of type 2 diabetes","volume":"32","author":"Abdul-Ghani","year":"2011","journal-title":"Endocr Rev"},{"key":"R27-22-20210129","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1056\/NEJMoa1504720","article-title":"Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes","volume":"373","author":"Zinman","year":"2015","journal-title":"N Engl J Med"},{"key":"R28-22-20210129","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1056\/NEJMoa1812389","article-title":"Dapagliflozin and cardiovascular outcomes in type 2 diabetes","volume":"380","author":"Wiviott","year":"2019","journal-title":"N Engl J Med"},{"key":"R29-22-20210129","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1056\/NEJMoa1611925","article-title":"Canagliflozin and cardiovascular and renal events in type 2 diabetes","volume":"377","author":"Neal","year":"2017","journal-title":"N Engl J Med"},{"key":"R30-22-20210129","first-page":"1","article-title":"Effects of SGLT2 inhibitors on UTIs and genital infections in type 2 diabetes mellitus: a systematic review and meta-analysis","volume":"7","author":"Liu","year":"2017","journal-title":"Nature"},{"key":"R31-22-20210129","doi-asserted-by":"crossref","first-page":"2654","DOI":"10.1016\/j.clinthera.2016.11.002","article-title":"SGLT2 inhibitor-associated diabetic ketoacidosis: clinical review and recommendations for prevention and diagnosis","volume":"38","author":"Goldenberg","year":"2016","journal-title":"Clin Ther"},{"key":"R32-22-20210129","doi-asserted-by":"crossref","first-page":"e47","DOI":"10.2337\/dc17-1721","article-title":"SGLT2 inhibitor-associated euglycaemic diabetic ketoacidosis: a South Australian clinical case series and Australian spontaneous adverse event notifications","volume":"41","author":"Meyer","year":"2018","journal-title":"Diabetes Care"},{"key":"R33-22-20210129","first-page":"1","article-title":"Ketoacidosis associated with SGLT2 inhibitor treatment: analysis of FAERS data","volume":"37","author":"Blau","year":"2017","journal-title":"Diabetes Metab Rev"},{"key":"R34-22-20210129","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/0310057X1804600202","article-title":"The good, the bad, and the ugly: sodium-glucose contransporter-2 inhibitors (gliflozins) and perioperative diabetes","volume":"46","author":"Kerridge","year":"2018","journal-title":"Anaesth Intensive Care"},{"key":"R35-22-20210129","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1002\/phar.1881","article-title":"SGLT2 inhibitors: a systematic review of diabetic ketoacidosis and related risk factors in the primary literature","volume":"37","author":"Burke","year":"2017","journal-title":"Pharmacotherapy"},{"key":"R36-22-20210129","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/s12630-017-1019-5","article-title":"Sodium-glucose contransporter-2 inhibitors (SGLT-2i) in the perioperative setting","volume":"65","author":"Peacock","year":"2018","journal-title":"Can J Anaesth"},{"key":"R37-22-20210129","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1213\/ANE.0000000000002377","article-title":"Perioperative considerations for the use of sodium-glucose cotransporter-2 inhibitors in patients with type 2 diabetes","volume":"126","author":"Peacock","year":"2018","journal-title":"Anesth Analg"},{"key":"R38-22-20210129","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1213\/ANE.0000000000002740","article-title":"New diabetes medications raise new perioperative concerns for the anesthesiologist","volume":"126","author":"DeCou","year":"2018","journal-title":"Anesth Analg"},{"key":"R39-22-20210129","first-page":"758","article-title":"Sodium-glucose linked transporter 2 inhibitor-associated perioperative euglycaemic diabetic ketoacidosis: a case for a perioperative guideline","volume":"45","author":"Hoffman","year":"2017","journal-title":"Anaesth Intensive Care"},{"key":"R40-22-20210129","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1007\/s12630-017-1018-6","article-title":"Perioperative implications of sodium-glucose cotransporter-2 inhibitors: a case series of euglycemic diabetic ketoacidosis in three patients after cardiac surgery","volume":"65","author":"Lau","year":"2018","journal-title":"Can J Anesth"},{"key":"R41-22-20210129","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1177\/0310057X1804600212","article-title":"Postoperative euglycaemic diabetic ketoacidosis associated with sodium-glucose cotransporter-2 inhibitors (gliflozins): a report of two cases and review of the literature","volume":"46","author":"Chacko","year":"2018","journal-title":"Anaesth Intensive Care"},{"key":"R42-22-20210129","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.soard.2015.08.502","article-title":"Normoglycemic ketoacidosis in a postoperative gastric bypass patient taking canagliflozin","volume":"12","author":"Bonanni","year":"2016","journal-title":"Surg Obes Relat Dis"},{"key":"R43-22-20210129","first-page":"A3825","article-title":"Euglycemic\u2019 diabetic ketoacidosis in the perioperative period: why gliflozins may not be so sweet after all!","volume":"195","author":"Lane","year":"2017","journal-title":"Am J Respir Crit Care Med"},{"key":"R44-22-20210129","first-page":"725","article-title":"Euglycaemic ketoacidosis in a post-operative Whipple patient using canaglifozin","volume":"2016","author":"Wood","year":"2016","journal-title":"BMJ Case Rep"},{"key":"R46-22-20210129","first-page":"424","article-title":"Perioperative management of sodium\u2013glucose cotransporter-2 inhibitors: importance of a nuanced approach","volume":"46","author":"Nanjappa","year":"2018","journal-title":"Anaesth Intensive Care"},{"key":"R47-22-20210129","first-page":"425","article-title":"Perioperative cessation of sodium\u2013glucose cotransporter-2 inhibitors: 72\u200ah or seven days?","volume":"46","author":"Tan","year":"2018","journal-title":"Anaesth Intensive Care"},{"key":"R49-22-20210129","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S2213-8587(16)30402-8","article-title":"Efficacy of sitagliptin for the hospital management of general medicine and surgery patients with type 2 diabetes (Sita-Hospital): a multicentre, prospective, open-label, noninferiority randomised trial","volume":"5","author":"Pasquel","year":"2017","journal-title":"Lancet Diabetes Endocrinol"},{"key":"R50-22-20210129","doi-asserted-by":"crossref","first-page":"S279","DOI":"10.2337\/dc11-s231","article-title":"Long-acting glucagon-like peptide-1 receptor agonists: a review of their efficacy and tolerability","volume":"34","author":"Garber","year":"2011","journal-title":"Diabetes Care"},{"key":"R51-22-20210129","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7573\/dic.212283","article-title":"A clinical review of GLP-1 receptor agonists: efficacy and safety in diabetes and beyond","volume":"4","author":"Prasad-Reddy","year":"2015","journal-title":"Drugs Context"},{"key":"R52-22-20210129","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1056\/NEJMoa1509225","article-title":"Lixisenatide in patients with type 2 diabetes and acute coronary syndrome","volume":"373","author":"Pfeffer","year":"2015","journal-title":"N Engl J Med"},{"key":"R53-22-20210129","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1056\/NEJMoa1603827","article-title":"Liraglutide and cardiovascular outcomes in type 2 diabetes","volume":"375","author":"Marso","year":"2016","journal-title":"N Engl J Med"},{"key":"R54-22-20210129","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1056\/NEJMoa1607141","article-title":"Semaglutide and cardiovascular outcomes in patients with type 2 diabetes","volume":"375","author":"Marso","year":"2016","journal-title":"N Engl J Med"},{"key":"R55-22-20210129","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1056\/NEJMoa1612917","article-title":"Effects of once-weekly exenatide on cardiovascular outcomes in type 2 diabetes","volume":"377","author":"Holman","year":"2017","journal-title":"N Engl J Med"},{"key":"R56-22-20210129","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1111\/dom.13028","article-title":"Design and baseline characteristics of participants in the Researching cardiovascular Events with a Weekly INcretin in Diabetes (REWIND) trial on cardiovascular effects with dulaglutide","volume":"20","author":"Gerstein","year":"2018","journal-title":"Diabetes Obes Metab"},{"key":"R57-22-20210129","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1111\/dom.13553","article-title":"Cardiovascular safety of oral semaglutide in patients with type 2 diabetes: rationale, design and patient baseline characteristics for the PIONEER 6 trial","volume":"21","author":"Bain","year":"2019","journal-title":"Diabetes Obes Metab"},{"key":"R58-22-20210129","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1111\/dom.13029","article-title":"Effects of continuous exenatide infusion on cardiac function and peri-operative glucose control in patients undergoing cardiac surgery: a single-blind, randomized controlled trial","volume":"19","author":"Lips","year":"2017","journal-title":"Diabetes Obes Metab"},{"key":"R59-22-20210129","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1111\/anae.14180","article-title":"Peri-operative management of patients with type-2 diabetes mellitus undergoing noncardiac surgery using liraglutide, glucose-insulin-potassium infusion or intravenous insulin bolus regimens: a randomised controlled trial","volume":"73","author":"Polderman","year":"2017","journal-title":"Anaesthesia"},{"key":"R60-22-20210129","doi-asserted-by":"crossref","first-page":"81","DOI":"10.4158\/EP12196.OR","article-title":"Management of hyperglycemia with the administration of intravenous exenatide to patients in the cardiac intensive care unit","volume":"19","author":"Abuannadi","year":"2013","journal-title":"Endocr Pract"},{"key":"R61-22-20210129","doi-asserted-by":"crossref","first-page":"256","DOI":"10.2337\/dc10-1407","article-title":"Randomized study of basal-bolus insulin therapy in the inpatient management of patients with type 2 diabetes undergoing general surgery (RABBIT 2 Surgery)","volume":"34","author":"Umpierrez","year":"2011","journal-title":"Diabetes Care"},{"key":"R62-22-20210129","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s41669-017-0020-9","article-title":"A comparison of inpatient cost per day in general surgery patients with type 2 diabetes treated with basal-bolus versus sliding scale insulin regimens","volume":"1","author":"Phillips","year":"2017","journal-title":"Pharmacoecon Open"},{"key":"R63-22-20210129","first-page":"141","article-title":"New insulin infusion protocol improves blood glucose control in hospitalized patients without increasing hypoglycemia","volume":"31","author":"Ku","year":"2005","journal-title":"Jt Comm J Qual Patient Saf"},{"key":"R64-22-20210129","doi-asserted-by":"crossref","first-page":"71","DOI":"10.4158\/EP.10.S2.71","article-title":"Intravenous insulin infusion therapy: indications, methods, and transition to subcutaneous insulin therapy","volume":"10","author":"Bode","year":"2004","journal-title":"Endocr Pract"},{"key":"R65-22-20210129","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1111\/dme.12756","article-title":"A guideline for the use of variable rate intravenous insulin infusion in medical inpatients","volume":"32","author":"George","year":"2015","journal-title":"Diabet Med"},{"key":"R66-22-20210129","doi-asserted-by":"crossref","first-page":"2104","DOI":"10.1007\/s11095-012-0739-z","article-title":"Design of the novel protraction mechanism of insulin degludec, an ultra-long-acting basal insulin","volume":"29","author":"Jonassen","year":"2012","journal-title":"Pharm Res"},{"key":"R67-22-20210129","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1111\/jdi.12409","article-title":"Evaluation of safety of insulin degludec on undergoing total colonoscopy using continuous glucose monitoring","volume":"7","author":"Takeishi","year":"2016","journal-title":"J Diabetes Investig"},{"key":"R68-22-20210129","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1210\/js.2018-00262","article-title":"Advances in glucose monitoring and automated insulin delivery: supplement to Endocrine Society Clinical Practice Guidelines","volume":"2","author":"Peters","year":"2018","journal-title":"J Endocr Soc"},{"key":"R69-22-20210129","doi-asserted-by":"crossref","first-page":"k1310","DOI":"10.1136\/bmj.k1310","article-title":"Artificial pancreas treatment for outpatients with type 1 diabetes: systematic review and meta-analysis","volume":"361","author":"Bekiari","year":"2018","journal-title":"BMJ"},{"key":"R70-22-20210129","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/S2213-8587(17)30167-5","article-title":"Effect of artificial pancreas systems on glycaemic control in patients with type 1 diabetes: a systematic review and meta-analysis of outpatient randomised controlled trials","volume":"5","author":"Weisman","year":"2017","journal-title":"Lancet Diabetes Endocrinol"},{"key":"R71-22-20210129","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1177\/1932296817706151","article-title":"Consensus statement on inpatient use of continuous glucose monitoring","volume":"11","author":"Wallia","year":"2017","journal-title":"J Diabetes Sci Technol"},{"key":"R72-22-20210129","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.2337\/dc17-1960","article-title":"Investigation of the accuracy of 18 marketed blood glucose monitors","volume":"41","author":"Klonoff","year":"2018","journal-title":"Diabetes Care"},{"key":"R73-22-20210129","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1177\/1932296816672237","article-title":"Comparative accuracy of 17 point-of-care glucose meters","volume":"11","author":"Ekhlaspour","year":"2017","journal-title":"J Diabetes Sci Technol"},{"key":"R75-22-20210129","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1097\/SLA.0000000000002989","article-title":"Enhanced recovery in patients with diabetes: is it time for a moratorium on use of preoperative carbohydrate beverages?","volume":"269","author":"Rushakoff","year":"2019","journal-title":"Ann Surg"},{"key":"R76-22-20210129","doi-asserted-by":"crossref","first-page":"e000460","DOI":"10.1136\/bmjdrc-2017-000460","article-title":"Inpatient diabetes management by specialized diabetes team versus primary service team in noncritical care units: impact on 30-day readmission rate and hospital cost","volume":"6","author":"Bansal","year":"2018","journal-title":"BMJ Open Diabetes Res Care"}],"container-title":["Current Opinion in Anaesthesiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00001503-201906000-00022","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,29]],"date-time":"2021-01-29T19:47:33Z","timestamp":1611949653000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00001503-201906000-00022"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6]]},"references-count":65,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1097\/aco.0000000000000735","relation":{},"ISSN":["0952-7907"],"issn-type":[{"value":"0952-7907","type":"print"}],"subject":[],"published":{"date-parts":[[2019,6]]}}}